Arkolith/Insider Trading/GNLX/Form 4

Yu Yong

SVP, Clinical DevelopmentGENELUX Corp (GNLX) · full profile →Form 4 · filed Dec 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Sell(S)973$5.37$5K146K
Aug 21, 2025Sell(S)3K$3.36$11K147K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-027338) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML